The House Committee on Energy and Commerce convened a markup opening in which the chairman outlined bills to increase price transparency in health care, classify xylazine under the Controlled Substances Act while protecting veterinary uses, study fentanyl testing in emergency departments, and allow some community health center funds for nutrition education.